ISMP Releases Guidelines on Safe Subcutaneous Insulin Use

For years, insulin has been shown to be associated with more medication error-related harm than any other drug. The new ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults are designed to help healthcare practitioners prevent errors and improve outcomes for patients with diabetes. The guidelines, based on a multidisciplinary consensus conference of experts, provide recommendations for avoiding at-risk behaviors involving subcutaneous insulin across the entire continuum of care, including prescribing, preparation and administration, monitoring, and patient education. The document also addresses evolving practices, devices, and technology that aim to enhance the safety of insulin use, such as with concentrated insulin and insulin pen devices. For a copy, visit: